Illuminating
the path
to patient
access.

Introducing NorstellaLinQ

The biopharma industry’s first fully integrated data asset.

See the Real Picture in Market Access

MMIT has evolved to better understand your struggles. We stay grounded in the data—and deliver much more clarity and context—to reveal the human realities behind market access challenges.

The State of Patient
Access 2025

Real-World
Data Solutions

What’s New

On-Demand Webinar

Uncovering New Rare
Disease Patients Using
Structured and
Unstructured
Real-World Data

Pharma Company

NEWLY DIAGNOSED PATIENTS

USE CASE

NorstellaLinQ: Gain
Real-Time Insights on
High-Risk Patient
Populations with
Real-World Data

EBOOK

Unlocking Patient
Access: How Rx
BIN/PCN/Group
Data Transforms
Benefit Verification
for Healthcare IT

Searchlight

MMIT's Searchlight:
Introducing Faster,
Smarter Policy Alerting

VIDEO

Delivering Timely,
Actionable RWD Insights

use case

HIT Company
Streamlines Benefit
Verification With
MMIT’s Analytics,
Bridging as a Service

VIDEO

Uncovering New Rare
Disease Patients Using
Structured and Unstructured
Real-World Data

case study

Closing Market Access Gaps
With MMIT’s Core Solutions

VIDEO

See how MMIT is
Illuminating the path
to Patient Access

use-case

Smoothing Patient Access
in Rare Disease

VIDEO

The Power of
Real-World Data

thought leadership

How Copay
Accumulators and
Maximizers Affect
Pharma PAPs

use-case

NorstellaLinQ: Targeting
Patients and Fueling
Brand Strategy with
Trigger Alerts

State of Patient Access Report

< 0

%

Percentage of pharma execs who report moving their access timelines earlier in the product lifecycle.

NorstellaLinQ

billion

Number of data points harnessed via our fully integrated data asset.

Market Research

Number of active panelists on MMIT’s payer panel.

“Throughout my 10 years in market access, I’ve been exposed to most of the top solutions, at times simultaneously. I’ve always found myself turning to MMIT because of their products’ ease of use and data integrity.”

Illuminatingthe path to patientaccess.

Introducing NorstellaLinQ

See the Real Picture in Market Access

The State of Patient Access 2025

Real-World Data Solutions

What’s New

Uncovering New Rare Disease Patients Using Structured and Unstructured Real-World Data

NorstellaLinQ: Gain Real-Time Insights on High-Risk Patient Populations with Real-World Data

Unlocking Patient Access: How Rx BIN/PCN/Group Data Transforms Benefit Verification for Healthcare IT

MMIT's Searchlight: Introducing Faster, Smarter Policy Alerting

Delivering Timely, Actionable RWD Insights

HIT Company Streamlines Benefit Verification With MMIT’s Analytics, Bridging as a Service

The Power ofReal-World Data

Drive HCP Engagement with Smarter Omnichannel Marketing

MMIT’s ReimbursementCodes APIs Speed Claim Review and Reduce Overpayments

Promotional Strategies

Using Coverage Data to Achieve Brand Goals

Uncovering New RareDisease Patients UsingStructured and UnstructuredReal-World Data

Closing Market Access GapsWith MMIT’s Core Solutions

See how MMIT isIlluminating the pathto Patient Access

Smoothing Patient Accessin Rare Disease

The Power ofReal-World Data

How CopayAccumulators andMaximizers AffectPharma PAPs

NorstellaLinQ: TargetingPatients and FuelingBrand Strategy withTrigger Alerts

State of Patient Access Report

%

NorstellaLinQ

billion

Market Research

Jai Persico,

National Account Executive,Neurocrine Biosciences

CONTACT US

Illuminating
the path
to patient
access.

The State of Patient
Access 2025

Real-World
Data Solutions

Uncovering New Rare
Disease Patients Using
Structured and
Unstructured
Real-World Data

NorstellaLinQ: Gain
Real-Time Insights on
High-Risk Patient
Populations with
Real-World Data

Unlocking Patient
Access: How Rx
BIN/PCN/Group
Data Transforms
Benefit Verification
for Healthcare IT

MMIT's Searchlight:
Introducing Faster,
Smarter Policy Alerting

Delivering Timely,
Actionable RWD Insights

HIT Company
Streamlines Benefit
Verification With
MMIT’s Analytics,
Bridging as a Service

The Power of
Real-World Data

Drive HCP Engagement
with Smarter
Omnichannel Marketing

MMIT’s
ReimbursementCodes
APIs Speed Claim
Review and Reduce
Overpayments

Uncovering New Rare
Disease Patients Using
Structured and Unstructured
Real-World Data

Closing Market Access Gaps
With MMIT’s Core Solutions

See how MMIT is
Illuminating the path
to Patient Access

Smoothing Patient Access
in Rare Disease

The Power of
Real-World Data

How Copay
Accumulators and
Maximizers Affect
Pharma PAPs

NorstellaLinQ: Targeting
Patients and Fueling
Brand Strategy with
Trigger Alerts

National Account Executive,
Neurocrine Biosciences